Mankind Pharma Limited EBITDA for the year ending March 31, 2025: USD 353.16 M

Mankind Pharma Limited EBITDA is USD 353.16 M for the year ending March 31, 2025, a 4.85% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Mankind Pharma Limited EBITDA for the year ending March 31, 2024 was USD 336.83 M, a 36.60% change year over year.
  • Mankind Pharma Limited EBITDA for the year ending March 31, 2023 was USD 246.58 M, a -12.79% change year over year.
  • Mankind Pharma Limited EBITDA for the year ending March 31, 2022 was USD 282.75 M, a 13.97% change year over year.
  • Mankind Pharma Limited EBITDA for the year ending March 31, 2021 was USD 248.09 M, a 21.33% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)